Yanli Bi

998 total citations · 1 hit paper
23 papers, 720 citations indexed

About

Yanli Bi is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yanli Bi has authored 23 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Yanli Bi's work include Ubiquitin and proteasome pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Autophagy in Disease and Therapy (3 papers). Yanli Bi is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), PI3K/AKT/mTOR signaling in cancer (4 papers) and Autophagy in Disease and Therapy (3 papers). Yanli Bi collaborates with scholars based in China, Madagascar and Estonia. Yanli Bi's co-authors include Yongchao Zhao, Linhao Xu, Xiufang Xiong, Danrui Cui, Zhongquan Sun, Weilin Wang, Zhengwei Mao, Yuan Ding, Binglin Ye and Lisha Yu and has published in prestigious journals such as Advanced Materials, Hepatology and Oncogene.

In The Last Decade

Yanli Bi

22 papers receiving 713 citations

Hit Papers

Mitochondrial‐Targeted Delivery of Polyphenol‐Mediated An... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanli Bi China 13 365 83 77 66 65 23 720
Hong Huang China 18 306 0.8× 52 0.6× 75 1.0× 83 1.3× 66 1.0× 43 889
Chunfang Liu China 16 549 1.5× 53 0.6× 71 0.9× 141 2.1× 71 1.1× 36 827
Renato José da Silva Oliveira Brazil 16 328 0.9× 49 0.6× 49 0.6× 125 1.9× 55 0.8× 41 800
Haloom Rafehi Australia 15 585 1.6× 46 0.6× 72 0.9× 124 1.9× 50 0.8× 32 1.0k
Vitale Del Vecchio Italy 16 273 0.7× 36 0.4× 46 0.6× 136 2.1× 87 1.3× 30 731
Jing Yao China 21 476 1.3× 38 0.5× 99 1.3× 78 1.2× 102 1.6× 53 1.0k
Maciej Małecki Poland 14 280 0.8× 50 0.6× 78 1.0× 97 1.5× 42 0.6× 83 732
Zühal Hamurcu Türkiye 17 372 1.0× 83 1.0× 34 0.4× 92 1.4× 120 1.8× 50 780
Ruiyan Pan China 17 249 0.7× 78 0.9× 35 0.5× 25 0.4× 65 1.0× 42 577
Sam Abbassi United States 10 393 1.1× 50 0.6× 81 1.1× 94 1.4× 39 0.6× 13 754

Countries citing papers authored by Yanli Bi

Since Specialization
Citations

This map shows the geographic impact of Yanli Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanli Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanli Bi more than expected).

Fields of papers citing papers by Yanli Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanli Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanli Bi. The network helps show where Yanli Bi may publish in the future.

Co-authorship network of co-authors of Yanli Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Yanli Bi. A scholar is included among the top collaborators of Yanli Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanli Bi. Yanli Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Linhao, et al.. (2024). Suppression of PERK/eIF2α/CHOP pathway enhances oridonin-induced apoptosis by inhibiting autophagy in Small-Cell lung cancer cells. Biomedicine & Pharmacotherapy. 175. 116684–116684. 7 indexed citations
2.
Zhang, Sitong, Zhongquan Sun, Zhenhua Chen, et al.. (2024). Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury. Hepatology. 81(3). 888–902. 12 indexed citations
5.
Bi, Yanli, Xiaoyu Chen, Bajin Wei, et al.. (2021). DEPTOR stabilizes ErbB2 to promote the proliferation and survival of ErbB2-positive breast cancer cells. Theranostics. 11(13). 6355–6369. 12 indexed citations
6.
Bi, Yanli, et al.. (2021). Nuclear ErbB2 represses DEPTOR transcription to inhibit autophagy in breast cancer cells. Cell Death and Disease. 12(4). 397–397. 11 indexed citations
7.
Shu, Jianfeng, Xiaoyu Chen, Hui Pan, et al.. (2021). DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals. Cancer Letters. 519. 263–276. 13 indexed citations
8.
Chen, Jingjing, Yingying Chen, Yu Wang, et al.. (2021). Prediction of Ovarian Cancer-Related Metabolites Based on Graph Neural Network. Frontiers in Cell and Developmental Biology. 9. 753221–753221. 6 indexed citations
9.
Xu, Linhao, Yanli Bi, Yizhou Xu, et al.. (2020). Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway. Journal of Cellular and Molecular Medicine. 24(8). 4480–4493. 54 indexed citations
10.
Lin, Min, et al.. (2020). Emerging role of FBXO22 in carcinogenesis. Cell Death Discovery. 6(1). 66–66. 29 indexed citations
11.
12.
Xiong, Xiufang, Danrui Cui, Yanli Bi, Yi Sun, & Yongchao Zhao. (2020). Neddylation modification of ribosomal protein RPS27L or RPS27 by MDM2 or NEDP1 regulates cancer cell survival. The FASEB Journal. 34(10). 13419–13429. 12 indexed citations
13.
Bi, Yanli, Danrui Cui, Xiufang Xiong, & Yongchao Zhao. (2020). The characteristics and roles of β‐TrCP1/2 in carcinogenesis. FEBS Journal. 288(11). 3351–3374. 44 indexed citations
14.
Chen, Xiaoyu, Xiufang Xiong, Danrui Cui, et al.. (2019). DEPTOR is an in vivo tumor suppressor that inhibits prostate tumorigenesis via the inactivation of mTORC1/2 signals. Oncogene. 39(7). 1557–1571. 36 indexed citations
15.
16.
Chen, Xiaoyu, Danrui Cui, Yanli Bi, et al.. (2018). AKT inhibitor MK-2206 sensitizes breast cancer cells to MLN4924, a first-in-class NEDD8-activating enzyme (NAE) inhibitor. Cell Cycle. 17(16). 2069–2079. 20 indexed citations
17.
Wang, Jingchao, Danrui Cui, Shanshan Gu, et al.. (2018). Autophagy regulates apoptosis by targeting NOXA for degradation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1865(8). 1105–1113. 23 indexed citations
18.
19.
Bi, Yanli. (2013). Risk factors of post-operative delirium and cognitive dysfunction in elderly patients undergoing hip joint replacement surgery. 3 indexed citations
20.
Bi, Yanli. (2002). AN ANALYTICAL DESIGN METHOD OF DISK CAM MECHANISM WITH OSCILLATING ROLLER FOLLOWER.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026